American Capital Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
American Capital Advisory's LLY Position: Q2 2026 in Review
American Capital Advisory increased its Eli Lilly (LLY) stake by 2% in Q2 2026, buying an estimated $10.2K and bringing the position to 519 shares worth $623K. The position accounts for 0.23% of the portfolio, ranked #68.
American Capital Advisory first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- American Capital Advisory held 519 shares of Eli Lilly worth $623K as of Q2 2026.
- American Capital Advisory bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
- Eli Lilly made up 0.23% of American Capital Advisory's portfolio in Q2 2026, its #68 holding.
- American Capital Advisory first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.